¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"ARGININE VEYRON ORAL SOLUTION"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
OHI Occupational Health Institute; operative hypertension indicator; oral hygiene index; Oral Hygiene In...
WHO ORS World Health Organization Oral Rehydration Solution osmolality 330; ¼¼°èº¸°Ç±â±¸ °æ±¸ ¼ö¾× ¿ë¾×
UW solution University of Wisconsin solution
BSS Bachelor of Sanitary Science; balanced salt solution; Bernard-Soulier syndrome; black silk suture; b...
HAS Hamilton Anxiety Scale; health advisory service; highest asymptomatic [dose]; hospital administrativ...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
FSCE Free Solution Capillary Electrophoresis
GBR Glutatione-bicarbonate-Ringer solution
HBSS Hank's Balanced Salt Solution
HSS hypertonic saline solution
PBS I--phosphate buffer solution
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • decontaminating solution
    ¿À¿°Á¦°Å¿ë¾×
  • etching solution
    ºÎ½Ä¿ë¾×
  • hyperbaric solution
    °íºñÁß¿ë¾×
  • hypertonic solution
    °íÀå¾×
  • hypotonic solution
    ÀúÀå¾×
  • heavy solution
    Áß¾×
  • half-normal solution
    ¹Ý±ÔÁ¤¾×
  • isotonic solution
    µîÀå¾×
  • Lugol¡¯s solution
    ·ç°ñ¿ë¾×
  • maintenance solution
    À¯Áö¿ë¾×
  • molar solution
    ¸ô¾×
  • normal saline solution
    »ý¸®½Ä¿°¼ö
  • ophthalmic solution
    ¾È°ú¿ë¾×
  • physiological salt solution
    »ý¸®½Ä¿°¼ö
  • perfect solution
    ÀÌ»ó¿ë¾×, ¿ÏÀü¿ë¾×
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • poor oral hygiene
    ±¸°­À§»ýºÒ·®
  • oral infection
    ÀԾȰ¨¿°, °æ±¸°¨¿°
  • oral intake
    °æ±¸¼·Ãë
  • oral medication
    °æ±¸Åõ¾à
  • oral
    1.ÀÔ-, ±¸°­-, 2.°æ±¸-, 3.±¸¼ú-, ¸»-
  • oral glucose tolerance test
    °æ±¸Æ÷µµ´çºÎÇϰ˻ç
  • oral ulcer
    ÀԱ˾ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • oral microbial flora
    ÀԾȹ̻ý¹°¹«¸®
  • oral habit
    ÀÔ½À°ü, ±¸º®
  • oral health
    ±¸°­À§»ý
  • oral hygiene
    ±¸°­À§»ý
  • oral focal v hyperplasia
    ÀԾȱ¹¼Ò»óÇÇÁõ½Ä
  • oral immunization
    °æ±¸¸é¿ªÈ­
  • oral infection
    ÀԾȰ¨¿°, °æ±¸°¨¿°
  • oral inoculation
    °æ±¸Åõ¿©
  • oral intake
    °æ±¸¼·Ãë
  • oral leukoplakia
    ÀԾȹé»öÆÇÁõ
  • oral hairy leukoplakia
    ÀÔ¾ÈÅйé»öÆÇÁõ
  • oral manifestation
    ÀԾȡÈÄ, ±¸°­Â¡ÈÄ, ÀԾȼҰß
  • oral medication
    °æ±¸Åõ¾à
  • oral medicine
    (¢¡dentistry) Ä¡°úÇÐ, Ä¡ÀÇÇÐ
  • oral microbiology
    ±¸°­¹Ì»ý¹°ÇÐ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Channings solution
    Âù´×¾×.
  • Chenzinsky-Plein solution
    þÁø½ºÅ²-Ç÷¹Àο°»ö¾×.
  • Earies solution
    Earle¿ë¾×
  • Fowlers solution
    ÆÄ¿ï·¯ ¾×
  • Hanks solution
    ÇÚÅ©¿ë¾×
  • Hanks solution
    ÇàÅ© ÆòÇü¿°¿ë¾×
  • Hartmann s hypotonic solution
    Çϸ£Æ®¸¸ÀúÀå¾×.
  • Hayem s solution
    ¾ÆÀ̾ä¿ë¾×.
  • Heidenhain s hematoxylin staining solution
    ÇÏÀ̵§ÇÏÀÎ Ç츶Åå½Ç¸° ¿°»ö¾×.
  • Locke s solution
    ·ÎÅ©¾×.
  • Lockes solution
    ·ÎÅ©¾×
  • Lockes solution
    ·ÎÅ©¾×(¡­äû).
  • Lugols solution
    ·ç°ñ¾× (±×¶÷¿°»ö¿ë ¸Å¿°Á¦)
  • Ringer s solution
    ¸µ°Å¾×.
  • Ringers solution
    ¸µ°Å¾×
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • buffer solution
    ¿ÏÃæ¾×(èÐõúäû)
  • buffering solution
    ¿ÏÃæ¾×.
  • cardioplegic solution
    ½ÉÁ¤Áö¿ë¾×(ãýïÎò­éÂäû)
  • cardioplegic solution
    ½ÉÁ¤Áö¿ë¾×.
  • cetrimide-citrate-saline solution
    ¼¼Æ®¸®¹ÌÀ̵å-±¸¿¬»ê-½Ä¿° ¿ë¾×
  • colloid solution
    ÄÝ·ÎÀ̵å¿ë¾×(¡­éÁäû), ±³Áú¿ë¾×
  • colloid solution
    ÄÝ·ÎÀ̵å¿ë¾×(¡­éÁäû).
  • conjugate solution
    ¦¿ë¾×(¡­éÁäû).
  • crystalloid solution
    Á¤Áú¾×.
  • crystalloid solution
    Á¤Áú¾×
  • culture solution
    ¹è¾ç¾×.
  • decontaminating solution
    Å»¿À¿°¿ë¾×
  • diluted ammonia solution<³ª> liquor ammon iae dulutus
    ¹±Àº ¾Ï¸ð´Ï¾Æ¼ö.
  • disclosing solution
    Ä¡ÅÂÂø»ö¾×(¡­ó·ßääû).
  • equimolecular solution
    µîºÐÀÚ¿ë¾×.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • hypertonic solution
    °íÀå¾×(ÍÔíåäû)
  • hypotonic solution
    ÀúÀå¾×(î¸íåäû)
  • ideal solution
    ÀÌ»ó ¿ë¾×(×âßÌéÁäû)
  • isoosmolar solution
    µîÀå¾×(Ôõíåäû)
  • isosmotic solution
    µî»ïÅõ¾×(Ôõß¶÷âäû)
  • isotonic solution
    µîÀå¾×(Ôõíåäû)
  • Knop's solution
    Å©³ô¿ë¾×(éÁäû)
  • Krebs-Ringer solution
    Å©·¾½º-¸µ°Å ¿ë¾×(éÁäû)
  • Locke's solution
    ·Ï ¿ë¾×(éÁäû)
  • Lugol's solution
    ·ç°ñ ¿ë¾×(éÁäû)
  • molar solution
    ¸ô ¿ë¾×(éÁäû)
  • osmolal solution
    ¿À½º¸ô¶ö ¿ë¾×(éÁäû)
  • osmolar solution
    ¿À½º¸ô¶ó¸£ ¿ë¾×(éÁäû)
  • percent solution
    ÆÛ¼¾Æ® ¿ë¾×(éÁäû)
  • saturated solution
    Æ÷È­ ¿ë¾×(øéûùéÁäû)
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • firing solution
    °íÁ¤¾×, Á¤Âø¾×
  • Harlmann sodium lactate solution
    Á¥»ê ³ªÆ®·ý ¿ë¾×, Çϸ£Æ®¸¸ ¿ë¾×, À¯»ê ³ªÆ®·ý ¿ë¾×
  • Hawship's solution
    ¾ÆÀÌ¾ä ¿ë¾×
  • hydrogen peroxide solution
    °ú»êÈ­ ¼ö¼Ò¼ö
  • hyperbaric solution
    °íºñÁß¾×
    ±âÁؾ׺¸´Ù ´õ Å« ºñÁßÀ» °®´Â ¿ë¾×. ¿¹¸¦ µé¸é ô¼ö ¸¶ÃëÁ¦·Î ô¼ö¾×ÀÇ ºñÁߺ¸´Ù Å« ºñÁßÀ» °®´Â ¾×ÀÌ ÁÖ»çµÇ¸é ÁÖ»ç ºÎÀ§ ¾Æ·¡ÂÊÀ¸·Î µµ´ÞÇÏ¿© ÀÌ ºÎÀ§°¡ ¸¶ÃëµÈ´Ù.
  • hypotonic salt solution
    ÀúÀå½Ä¿°¼ö
  • interstitial solid solution
    ħÀÔÇü °í¿ëü
    ¿ë¸Å ±Ý¼ÓÀÇ °áÁ¤°ÝÀÚ »çÀÌ¿¡ ¿ëÁú ¿øÀÚ°¡ µé¾î°£ ±¸Á¶ÀÇ °í¿ëü.
  • isotonic solution
    µîÀ强 ¿ë¾×, µîÀå¾×
  • lactated Ringer's solution
    À¯»êÀ» °¡ÇÑ ¸µ°Å ¾×
  • Naegeli's solution
    ³×°Ö¸® ¿ë¾×
    È¿¸ð, °õÆÎÀÌ µî¿¡ »ç¿ëÇÏ´Â Àΰø ¹èÁö·Î, ÀÌ¿°±â¼º Àλê Ä®·ý 0.2g, ¿°È­ Ä®½· 0.1g, ÁÖ¼®»ê ¾Ï¸ð´½ 10gÀ» ¹° 1,000cc¿¡ ³ìÀÎ °Í.
  • normal saline solution
    Á¤¼º »ý¸® ½Ä¿°¼ö
  • novocaine solution
    ³ëº¸ÄÉÀÎ ¿ë¾×
  • ophthalmic solution
    ¾È°ú¿ë ¾×Á¦
  • parenteral solution
    ÁÖ»ç¾×
  • povidone-iodine solution

    powder (ºÐ¸», »êÁ¦

    °íÇüÀÇ ¾à¹°À» °¥°Å³ª ºÎ½¤ ¾òÀº ¼Ò¸³ÀÚÀÇ ÁýÇÕü.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
arginine vasopressin [8-arginine]vasopressin; [Arg8]vasopressin;vasopressin containing an arginyl residue in position 8 (as in chickens and most mammals, including man); porcine vasopressin has a lysyl residue at position 8. All are vasopressors.
Synonym: argipressin.
(05 Mar 2000)
arginine vasotocin Vasotocin with arginyl residue at position 8 (identical with arginine oxytocin).
See: arginine vasopressin.
(05 Mar 2000)
beta-alanyl-arginine hydrolase <enzyme> Also hydrolyzes carnosine, at a lower rate; requires mn2+; inhibited by bestatin; stabilised by sulfhydryl reagents
Registry number: EC 3.4.13.-
Synonym: ala-arg hydrolase
(26 Jun 1999)
calcium-calmodulin-activated histone 3 arginine kinase <enzyme> From nuclear extracts of dividing and quiescent rat heart endothelial cells; represents a new class of ca-cam-dependent kinases which phosphorylate arg
Registry number: EC 2.7.10.-
Synonym: ca(2+)-calmodulin-activated histone 3 arg kinase, ca-cam h3 kinase
(26 Jun 1999)
complement 5a, des-arginine Complement 5a with the carboxy-terminal arginine removed. The arginine is rapidly cleaved from the c5a fragment during complement activation by carboxypeptidase b present in normal human serum. C5a des-arg shows complete loss of spasmogenic activity though it retains some chemotactic ability.
(12 Dec 1998)
protein-arginine n-methyltransferase <enzyme> An enzyme that catalyses the methylation of arginine residues of proteins to yield n-mono- and n,n-dimethylarginine. This enzyme is found in many organs, primarily brain and spleen.
Chemical name: S-Adenosyl-L-methionine:protein-L-arginine N-methyltransferase
Registry number: EC 2.1.1.23
(12 Dec 1998)
NAD(p)-arginine ADP-ribosyltransferase <enzyme> An enzyme that catalyses the transfer of the ADP-ribose moiety from NAD to specific protein substrates with agmatine, arginine-type compounds, or guanidine as acceptors. This reaction can be catalyzed by prokaryotic and eukaryotic enzyme systems. Mono-ADP-ribosylation is a mechanism of action common to several bacterial toxins. It effects profound changes in cellular metabolism, such as activation of adenylate cyclase, regulation of protein synthesis at the level of elongation factor 2, and ion transport across biological membranes.
Chemical name: NAD(+)-L-arginine ADP-D-ribosyltransferase
Registry number: EC 2.4.2.31
(12 Dec 1998)
N-arginine dibasic convertase <enzyme> Catalyses cleavage at the n-terminus of arginine residues in dibasic stretches of proteins; located in brain cortex; genbank l27124
Registry number: EC 3.4.24.-
Synonym: nrd convertase, n-arg dibasic convertase
(26 Jun 1999)
acetic solution A vinegar.
(05 Mar 2000)
amaranth solution A 1% solution of amaranth (trisodium naphthol sulfonic acid), a synthetic vivid red dye, stable in acid and intensified in sodium hydroxide solution; used as a red or pink colourant in liquid pharmaceuticals.
(05 Mar 2000)
aqueous solution <chemistry> A solution in which water is the dissolving medium or solvent.
(09 Jan 1998)
barium solution A liquid containing barium sulfate, which shows up on X-rays. It outlines organs of the body so they can be seen on X-ray film.
(12 Dec 1998)
Benedict's solution <chemistry> An aqueous solution of sodium citrate, sodium carbonate, and copper sulfate which changes from its normal blue colour to orange, red, or yellow in the presence of a reducing sugar such as glucose.
See: Benedict's test for glucose.
(14 Aug 2000)
Burow's solution A preparation of aluminium subacetate and glacial acetic acid, used for its antiseptic and astringent action on the skin.
(05 Mar 2000)
Gallego's differentiating solution A dilute solution of formaldehyde and acetic acid used in a modified Gram stain to differentiate and enhance the basic fuchsin binding to Gram-negative microorganisms.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á